Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
MNPR | Monopar Therapeutics | Chief Scientific Officer, Director | $94.4K | Mar 31, 2022 | ||
ACTU | ACTUATE THERAPEUTICS, INC. | Chief Operating Officer | Aug 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|